NIC
DNA icon

Northwest Investment Counselors’s Ginkgo Bioworks DNA Stock Holding History

Northwest Investment Counselors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2
Closed -$123 – 231
2023
Q3 		$123 Buy
+2
New +$160 ﹤0.01% 567

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northwest Investment Counselors's DNA Position: Q4 2023 in Review

Northwest Investment Counselors sold out of Ginkgo Bioworks (DNA) in Q4 2023, closing a stake of 2 shares — an estimated $123 sold.

Northwest Investment Counselors first reported a position in DNA in Q3 2023 and held it in 1 quarter. The position peaked at $123 in Q3 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q4 2023.

  • Northwest Investment Counselors reported no remaining Ginkgo Bioworks position as of Q4 2023 after selling out during the quarter.
  • Northwest Investment Counselors sold 2 Ginkgo Bioworks shares in Q4 2023, an estimated $123.
  • Northwest Investment Counselors first reported a position in Ginkgo Bioworks in Q3 2023 and held it in 1 quarter.
  • Northwest Investment Counselors's Ginkgo Bioworks position peaked at $123 in Q3 2023.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2023.

Based on Northwest Investment Counselors's 13F filing for Q4 2023, filed 19 Jan 2024.